These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26589472)

  • 21. Pulmonary embolism: update on management and controversies.
    Duffett L; Castellucci LA; Forgie MA
    BMJ; 2020 Aug; 370():m2177. PubMed ID: 32759284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities.
    Prandoni P; Barbar S; Milan M; Vedovetto V; Pesavento R
    Eur J Intern Med; 2014 Jan; 25(1):25-30. PubMed ID: 24120221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Update on Current Care Guideline: Venous thromboembolism (VTE): deep venous thrombosis and pulmonary embolism].
    Duodecim; 2016; 132(7):683-4. PubMed ID: 27188093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment Options in Massive and Submassive Pulmonary Embolism.
    Wadhera RK; Piazza G
    Cardiol Rev; 2016; 24(1):19-25. PubMed ID: 26274535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct oral anticoagulants as alternative treatment options for the effective long-term treatment of patients with pulmonary embolism in primary care: a review.
    Toth PP
    Ann Med; 2014 Sep; 46(6):341-52. PubMed ID: 24888386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contemporary treatment of venous thromboembolic disease.
    Galanis T; Merli GJ
    Cardiol Clin; 2015 Feb; 33(1):49-57. PubMed ID: 25439330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New oral anticoagulants for the treatment of venous thromboembolism.
    Agnelli G; Becattini C; Franco L
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):151-61. PubMed ID: 23953903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of fibrinolysis and interventional therapy for acute venous thromboembolism.
    Emmerich J; Meyer G; Decousus H; Agnelli G
    Thromb Haemost; 2006 Sep; 96(3):251-7. PubMed ID: 16953264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experiences with temporary vena cava filters in 114 at-risk patients with thrombosis or thromboembolism].
    Scholz KH; Just M; Buchwald AB; Werner GS; Stille-Siegener M; Kreuzer H
    Dtsch Med Wochenschr; 1999 Mar; 124(11):307-13. PubMed ID: 10209531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of a retrievable vena cava filter with low-intensity anticoagulation for prevention of pulmonary embolism in patients with cancer: an observational study in 106 cases.
    Damascelli B; Ticha V; Patelli G; Lanocita R; Morosi C; Civelli E; Di Tolla G; Frigerio LF; Ciceri E; Garbagnati F; Spreafico C; Amadeo P; Marchianò A
    J Vasc Interv Radiol; 2011 Sep; 22(9):1312-9. PubMed ID: 21680201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New therapeutic approaches to pulmonary embolism: trials' results and significance of direct oral anticoagulants].
    Pizarro C; Hammerstingl C; Schaefer C; Grohé C; Nickenig G; Skowasch D
    Pneumologie; 2015 Feb; 69(2):99-110. PubMed ID: 25668610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venous interruption as prophylaxis of pulmonary embolism: vena cava filters.
    Cotroneo AR; Di Stasi C; Cina A; Di Gregorio F
    Rays; 1996; 21(3):461-80. PubMed ID: 9063063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of venous thrombo-embolism: an update.
    Konstantinides S; Torbicki A
    Eur Heart J; 2014 Nov; 35(41):2855-63. PubMed ID: 25179762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venous thromboembolism: anticoagulation, lysis, or filter?
    Robison JG; Elliott BM
    J S C Med Assoc; 1991 Aug; 87(8):413-7. PubMed ID: 1943028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interventional approaches in VTE treatment (vena cava filters, catheter-guided thrombolysis, thrombosuction).
    Imberti D; Maraldi C; Gallerani M
    Semin Respir Crit Care Med; 2012 Apr; 33(2):176-85. PubMed ID: 22648490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Massive pulmonary embolism in spite of temporary vena caval filter.
    Brodmann M; Gary T; Pilger E
    Vasa; 2010 Feb; 39(1):111-4. PubMed ID: 20186685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vena cava filter use in cancer patients with acute venous thromboembolism in California.
    Ho G; Brunson A; White R; Wun T
    Thromb Res; 2015 May; 135(5):809-15. PubMed ID: 25747821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cost-utility of dabigatran etexilate compared with warfarin in treatment and extended anticoagulation of acute VTE in the UK.
    Jugrin AV; Ustyugova A; Urbich M; Lamotte M; Sunderland T
    Thromb Haemost; 2015 Oct; 114(4):778-92. PubMed ID: 26272227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of Medical Therapies for the Management of Pulmonary Embolism.
    Panahi L; Udeani G; Horseman M; Weston J; Samuel N; Joseph M; Mora A; Bazan D
    Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33530544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.